Gabapentin and Relapsing-remitting multiple sclerosis - a phase IV clinical study of FDA data
Summary:
Relapsing-remitting multiple sclerosis is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are male, 40-49 old, also take Vitamin D3, and have Secondary progressive multiple sclerosis.
The phase IV clinical study analyzes which people have Relapsing-remitting multiple sclerosis when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,990 Gabapentin users. Check the latest studies of Gabapentin.
What is Relapsing-remitting multiple sclerosis?
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
313,421 people reported to have side effects when taking Gabapentin.
Among them, 212 people (0.07%) have Relapsing-remitting multiple sclerosis.
Among these 212 people:
What is the gender of people who have Relapsing-remitting multiple sclerosis when taking Gabapentin? *
What is the age of people who have Relapsing-remitting multiple sclerosis when taking Gabapentin? *
What are other drugs people take besides Gabapentin? *
What are other side effects people have besides Relapsing-remitting multiple sclerosis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and have Relapsing-remitting multiple sclerosis?
- Check whether Relapsing-remitting multiple sclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Gabapentin:
- Gabapentin (322,990 reports)
Relapsing-remitting multiple sclerosis treatments and more:
- Relapsing-remitting multiple sclerosis (76,275 reports)
How severe was Relapsing-remitting multiple sclerosis and when was it recovered:
Expand to all the drugs that have ingredients of gabapentin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gabapentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Relapsing-remitting multiple sclerosis:
- Relapsing-remitting multiple sclerosis (126 drugs)
Browse all the conditions that are associated with Relapsing-remitting multiple sclerosis:
- Relapsing-remitting multiple sclerosis (178 conditions)
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cimzia cause Arthritis? - a second ago
- Could Rapamune cause Ulcerative Colitis? - 4 seconds ago
- Drug interactions of Prednisone and Claritin - 6 seconds ago
- Could Norflex cause Epicondylitis? - 7 seconds ago
- Could Amino Acids cause Nausea? - 7 seconds ago
- Pepcid vs. Aleve, side effect and effectiveness comparison - 7 seconds ago
- Drug interactions of Viibryd and Calcium Citrate - 10 seconds ago
- Drug interactions of Imodium and Clonidine - 11 seconds ago
- Could Carboplatin cause Abdominal Adhesions? - 13 seconds ago
- Chronic Lymphocytic Leukaemia and Gastric Cancer - 13 seconds ago